Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000847
Filing Date
2025-03-27
Accepted
2025-03-27 07:17:24
Documents
91
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2244027
2 ex4-11.htm EX-4.11 30155
3 ex19-1.htm EX-19.1 6466
4 ex21-1.htm EX-21.1 6741
5 ex23-1.htm EX-23.1 4515
6 ex31-1.htm EX-31.1 18787
7 ex31-2.htm EX-31.2 18859
8 ex32-1.htm EX-32.1 8663
9 ex32-2.htm EX-32.2 8793
  Complete submission text file 0001641172-25-000847.txt   9539903

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE aim-20241231.xsd EX-101.SCH 66739
11 XBRL CALCULATION FILE aim-20241231_cal.xml EX-101.CAL 84312
12 XBRL DEFINITION FILE aim-20241231_def.xml EX-101.DEF 285413
13 XBRL LABEL FILE aim-20241231_lab.xml EX-101.LAB 602941
14 XBRL PRESENTATION FILE aim-20241231_pre.xml EX-101.PRE 451831
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1388357
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-27072 | Film No.: 25775263
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)